WCM
GCVRZ

Waterstone Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Waterstone Capital Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-70,981
Closed -$143K – 34
2013
Q3 		$143K Sell
70,981
-101,610
-59% -$194K 0.02% 31
2013
Q2 		$328K Buy
+172,591
New +$303K 0.03% 38

Other funds holding GCVRZ

FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Waterstone Capital Management's GCVRZ Position: Q4 2013 in Review

Waterstone Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2013, closing a stake of 70,981 shares — an estimated $143K sold.

Waterstone Capital Management first reported a position in GCVRZ in Q2 2013 and held it in 2 quarters. The position peaked at $328K in Q2 2013. 130 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2013.

  • Waterstone Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2013 after selling out during the quarter.
  • Waterstone Capital Management sold 70,981 Sanofi Contingent Value Rights shares in Q4 2013, an estimated $143K.
  • Waterstone Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 2 quarters.
  • Waterstone Capital Management's Sanofi Contingent Value Rights position peaked at $328K in Q2 2013.
  • 130 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2013.

Based on Waterstone Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.